Short description
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
Description
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug capable of delivering a disease-modifying approach and preserving cognition in patients.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
New Haven, Connecticut, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noaccessforu, Noaccess, Nopepepe, Noaccessforu, Noaccess, Noaccess
Sign in for full access
Founders
Paul Fonteyne, Stephen Bloch, Stephen M. Strittmatter, Timothy Siegert